Rankings
▼
Calendar
RMD Q4 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
Q4 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1.2B
+9.0% YoY
Gross Profit
$704M
57.6% margin
Operating Income
$381M
31.2% margin
Net Income
$292M
23.9% margin
EPS (Diluted)
$1.98
QoQ Revenue Growth
+2.2%
Cash Flow
Operating Cash Flow
$440M
Free Cash Flow
$414M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$6.9B
Total Liabilities
$2.0B
Stockholders' Equity
$4.9B
Cash & Equivalents
$238M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.1B
+9.0%
Gross Profit
$704M
$617M
+14.1%
Operating Income
$381M
$275M
+38.5%
Net Income
$292M
$230M
+27.2%
Revenue Segments
Sleep And Respiratory
$1.1B
88%
Software As Service
$152M
12%
← FY 2024
All Quarters
Q1 2025 →